Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

Gregory M Pastores, Barry E Rosenbloom, MD, Neal J Weinreb, Ozlem Goker-Alpan, Rebecca Mardach, Mark Lipson, Jennifer Ibrahim, Gabriel M Cohn, David Zahrieh, Pramod K Mistry

Blood (2011) 118 (21): 1101.

https://doi.org/10.1182/blood.V118.21.1101.1101

Published: 2011

Journal Articles

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

Alan G. Ramsay, PhD, Gullu Gorgun, PhD, Tobias A.W. Holderried, David Zahrieh, MS, Fenglong Liu, PhD, John Quackenbush, PhD, Carlo M. Croce, MD, John G. Gribben, MD, DSc

Blood (2008) 112 (11): 30.

https://doi.org/10.1182/blood.V112.11.30.30

Published: 2008

Journal Articles

A Phase II Study of Dasatinib in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL/SLL).

Philip C. Amrein, MD, Eyal C. Attar, M.D., Tak Takvorian, M.D., Ephraim P. Hochberg, M.D., Karen Ballen, M.D., David Zahrieh, M.S., Jennifer R. Brown, M.D.

Blood (2007) 110 (11): 3126.

https://doi.org/10.1182/blood.V110.11.3126.3126

Published: 2007

Journal Articles

Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens.

Melinda A. Biernacki, Ovidiu Marina, Liu Fenglong, Ingmar Bruns, MD, David Zahrieh, Wandi Zhang, Christine Canning, PA-C, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Jerome Ritz, MD, Catherine J. Wu, MD

Blood (2007) 110 (11): 1799.

https://doi.org/10.1182/blood.V110.11.1799.1799

Published: 2007

Journal Articles

Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide

Katja Mauerer Zirlik, David Zahrieh, Donna Neuberg, John G. Gribben

Blood (2006) 108 (12): 3865–3870.

https://doi.org/10.1182/blood-2006-04-014415

Published: 2006

Journal Articles

Costs of Complications after Allogeneic Myeloablative Stem Cell Transplantation.

Akiko M. Saito, MD, PhD, Corey Cutler, MD, MPH, FRCPC, David Zahrieh, MS, Vincent T. Ho, MD, Edwin P. Alyea, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Stephanie J. Lee, MD, MPH

Blood (2006) 108 (11): 2977.

https://doi.org/10.1182/blood.V108.11.2977.2977

Published: 2006

Journal Articles

X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis

Ross L. Levine, Claude Belisle, Martha Wadleigh, David Zahrieh, Stephanie Lee, Pierre Chagnon, D. Gary Gilliland, Lambert Busque

Blood (2006) 107 (10): 4139–4141.

https://doi.org/10.1182/blood-2005-09-3900

Published: 2006

Journal Articles

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

John G. Gribben, David Zahrieh, Katherine Stephans, Lini Bartlett-Pandite, Edwin P. Alyea, David C. Fisher, Arnold S. Freedman, Peter Mauch, Robert Schlossman, Lecia V. Sequist, Robert J. Soiffer, Blossom Marshall, Donna Neuberg, Jerome Ritz, Lee M. Nadler

Blood (2005) 106 (13): 4389–4396.

https://doi.org/10.1182/blood-2005-05-1778

Published: 2005

Journal Articles

Successful Generation of Cytotoxic T-Cells That Kill CLL Cells Using Heteroclitic Peptides Is Independent of the Native Peptide Binding Affinity to HLA-A*0201.

Katja Mauerer, MD, Gullu Gorgun, PhD, David Zahrieh, MSc, John G. Gribben, MD DSc

Blood (2005) 106 (11): 54.

https://doi.org/10.1182/blood.V106.11.54.54

Published: 2005

Journal Articles

Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation.

Akiko M. Saito, MD, PhD, Corey Cutler, MD, MPH, FRCPC, David Zahrieh, MS, Robert J. Soiffer, MD, Vincent T. Ho, MD, Edwin P. Alyea, MD, Joseph H. Antin, MD, Stephanie J. Lee, MD, MPH

Blood (2005) 106 (11): 1797.

https://doi.org/10.1182/blood.V106.11.1797.1797

Published: 2005

Journal Articles

CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL.

Gullu Gorgun, PhD, Tobias A.W. Holderried, Rifca Ledieu, MD, David Zahrieh, MS, John G. Gribben, MD,DSc.

Blood (2005) 106 (11): 50.

https://doi.org/10.1182/blood.V106.11.50.50

Published: 2005

Journal Articles

Mixed Hematopoietic Chimerism for Sickle Cell Disease Prevents Intravascular Hemolysis and Corrects Biomarkers of Endothelial Function.

Catherine J. Wu, MD, Lakshmanan Krishnamurti, MD, Mark T. Gladwin, MD, Melinda Biernacki, Shelby A. Rogers, Xunde Wang, David Zahrieh, Joseph H. Antin, MD, Jerome Ritz, MD

Blood (2005) 106 (11): 2333.

https://doi.org/10.1182/blood.V106.11.2333.2333

Published: 2005

Journal Articles

Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells

Clair S. Gricks, David Zahrieh, A. Jason Zauls, Gullu Gorgun, Daniela Drandi, Katja Mauerer, Donna Neuberg, John G. Gribben

Blood (2004) 104 (13): 4002–4009.

https://doi.org/10.1182/blood-2004-02-0494

Published: 2004

Includes: Supplemental data

Journal Articles

Somatic Hypermutation Does Not Increase the Binding Affinity of Ig Derived Peptides to MHC Class I or II - Implications for Ig Peptide Vaccination Strategies.

Katja Mauerer, MD, David Zahrieh, MSc, Sascha Ansen, MD, Aihong Li, MD, PhD, Zhinan Xia, PhD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 960.

https://doi.org/10.1182/blood.V104.11.960.960

Published: 2004

Journal Articles

Distinct VDJ-H Gene Usage between Mutated and Unmutated Patients in B-CLL: Implications for Pathogenesis and Correlation with Clinical Outcome.

Katja Mauerer, MD, David Zahrieh, MSc, Gullu Gorgun, PhD, Aihong Li, MD PhD, Jianbiao Zhou, MD MSc, Laura Rassenti, PhD, John G. Gribben, MD DSc

Blood (2004) 104 (11): 970.

https://doi.org/10.1182/blood.V104.11.970.970

Published: 2004

Journal Articles

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Vassiliki Rizouli, MD, David Zahrieh, MS, Gullu Gorgun, PhD, Tobias A.W. Holderried, Carlo Croce, MD, John G. Gribben, MD, DSc

Blood (2004) 104 (11): 180.

https://doi.org/10.1182/blood.V104.11.180.180

Published: 2004

Journal Articles

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

Stephanie J. Lee, David Zahrieh, Edward Agura, Margaret L. MacMillan, Richard T. Maziarz, Philip L. McCarthy, Jr, Vincent T. Ho, Corey Cutler, Edwin P. Alyea, Joseph H. Antin, Robert J. Soiffer

Blood (2004) 104 (5): 1559–1564.

https://doi.org/10.1182/blood-2004-03-0854

Published: 2004

Journal Articles

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Vincent T. Ho, David Zahrieh, Ephraim Hochberg, Eileen Micale, Jesse Levin, Carol Reynolds, Steve Steckel, Corey Cutler, David C. Fisher, Stephanie J. Lee, Edwin P. Alyea, Jerome Ritz, Robert J. Soiffer, Joseph H. Antin

Blood (2004) 104 (4): 1224–1226.

https://doi.org/10.1182/blood-2004-01-0028

Published: 2004

Journal Articles

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Martha Wadleigh, Paul G. Richardson, David Zahrieh, Stephanie J. Lee, Corey Cutler, Vincent Ho, Edwin P. Alyea, Joseph H. Antin, Richard M. Stone, Robert J. Soiffer, Daniel J. DeAngelo

Blood (2003) 102 (5): 1578–1582.

https://doi.org/10.1182/blood-2003-01-0255

Published: 2003

Journal Articles

Comparison of T-cell–depleted and non–T-cell–depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs

Stephanie J. Lee, David Zahrieh, Edwin P. Alyea, Edie Weller, Vincent T. Ho, Joseph H. Antin, Robert J. Soiffer

Blood (2002) 100 (8): 2697–2702.

https://doi.org/10.1182/blood-2002-03-0984

Published: 2002

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Report on the Safety of Velaglucerase Alfa Enzyme Replacement Therapy in Patients with Type 1 Gaucher Disease and the Transition From Clinic to Home Infusions During Treatment Protocol HGT-GCB-058

A Mouse Model for Immunotherapeutic Reversal of Leukemia-Induced T Cell Dysfunction

A Phase II Study of Dasatinib in Relapsed and Refractory Chronic Lymphocytic Leukemia (CLL/SLL).

Proteomics To Identify Novel Immune-Targeted CML Stem Cell Antigens.

Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide

Costs of Complications after Allogeneic Myeloablative Stem Cell Transplantation.

X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis

Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia

Successful Generation of Cytotoxic T-Cells That Kill CLL Cells Using Heteroclitic Peptides Is Independent of the Native Peptide Binding Affinity to HLA-A*0201.

Comparison of Methotrexate- Versus Sirolimus- Containing Graft-Versus-Host Disease Prophylaxis Regimens after Myeloablative Stem Cell Transplantation.

CLL Cells in TCL1 Transgenic Mice Induce Similar Defects in CD4 and CD8 T Cells to Those Observed in Patients with CLL.

Mixed Hematopoietic Chimerism for Sickle Cell Disease Prevents Intravascular Hemolysis and Corrects Biomarkers of Endothelial Function.

Differential regulation of gene expression following CD40 activation of leukemic compared to healthy B cells

Somatic Hypermutation Does Not Increase the Binding Affinity of Ig Derived Peptides to MHC Class I or II - Implications for Ig Peptide Vaccination Strategies.

Distinct VDJ-H Gene Usage between Mutated and Unmutated Patients in B-CLL: Implications for Pathogenesis and Correlation with Clinical Outcome.

Gene Expression Profiling Identifies Similar CD4 + and CD8 + T Cell Defects in TCL1 Transgenic Mice after Development of CLL to Those Observed in Patients with CLL.

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

Comparison of T-cell–depleted and non–T-cell–depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only